NCT06808295

Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients

Dexmedetomidine As an Effective Drug in Reducing Anesthetic Requirements in Patients Undergoing External Dacrocystorhinostomy, a Randomized Controlled Study

• Status: Recruiting
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Research Institute of Ophthalmology, Egypt · Academic / Other
• Sex: All
• Age: 16 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative

Detailed description

Dexmedetomidine is a highly selective alpha 2 adrenoceptor agonist, having characteristics of natural sleep like sedation, can reduce pain intensity and opioid consumption without influencing the time of recovery from general anesthesia

Conditions

• Patients Undergoing External Dacrocystorhinostomy Operations
• Assess Decreased Anesthetic Requirements Intraoperative

Interventions

Type	Name	Description
DRUG	Dexmedetomidine Hydrochloride	drug will be given before induction and anesthetic doses and hemodynamics will be assessed pre- intra and postoperative

Timeline

• Start date: 2024-04-16
• Primary completion: 2025-04-20
• Completion: 2025-05-01
• First posted: 2025-02-05
• Last updated: 2025-02-05

Locations

1 site across 1 country: Egypt